Immune system

Topical Magnesium is the Best Way to Get the Essential Mineral to Keep Your Body in Optimal Condition

Thursday, September 23, 2021 - 7:32pm

Beyond the enjoyment factor, topical application of magnesium is the best way to increase cellular magnesium levels.

Key Points: 
  • Beyond the enjoyment factor, topical application of magnesium is the best way to increase cellular magnesium levels.
  • The best way to get magnesium into your body is with topical application of quality magnesium oils, gels,and bath crystals.
  • Magnesium Gel: Less concentrated, Magnesium Gel provides the benefits of purified magnesium chloride formulated with seaweed extract for people with more sensitive skin.
  • We want them to know that topical magnesium application is the best way to meet theirnecessary magnesium requirements.

Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com

Thursday, September 23, 2021 - 1:37pm

New York, NY, and Tel Aviv, ISRAEL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced an expansion of its Tollovid® dietary supplement 3CL protease (MPro) inhibitor immune support product line with the launch of Tollovid Daily™ via subscription. The subscription model takes the hassle out of remembering to order Tollovid Daily on a monthly basis. 

Key Points: 
  • New York, NY, and Tel Aviv, ISRAEL, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (Todos Medical) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced an expansion of its Tollovid dietary supplement 3CL protease (MPro) inhibitor immune support product line with the launch of Tollovid Daily via subscription .
  • Both Tollovid and Tollovid Daily are 3CL protease inhibitors for immune support that have 60 caplets per bottle.
  • Tollovid Daily was designed as a twice-daily dosing schedule for people on the go that provides one month of daily immune support.
  • Tollovid Daily is an affordable immune support solutionwith mass market appeal, said Gerald Commission CEO of Todos Medical.

Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress

Thursday, September 23, 2021 - 1:01pm

CDX-0159 is a humanized monoclonal antibody that specifically binds the receptor tyrosine kinase KIT with high specificity and potently inhibits its activity.

Key Points: 
  • CDX-0159 is a humanized monoclonal antibody that specifically binds the receptor tyrosine kinase KIT with high specificity and potently inhibits its activity.
  • KIT is expressed in a variety of cells, including mast cells, which mediate inflammatory responses such as hypersensitivity and allergic reactions.
  • In certain inflammatory diseases, such as chronic urticaria, mast cell activation plays a central role in the onset and progression of the disease.
  • Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.

U.S. Dept. of Health and Human Services Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2

Thursday, September 23, 2021 - 3:00pm

With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies.

Key Points: 
  • With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies.
  • The study of respiratory health, diseases and treatments is typically done through animal studies or culture models using animal or human cells.
  • BARDA's ImmuneChip+ program requires that all applicants already have a mature, validated tissue chip, in this case the lung.
  • To develop an organ-on-a-chip, human cells are used to manufacture 3D organ-like structures.

Multivitamin Vegan Zinc Vitamin B12 Tablet Supplements for Immune Support from Boost Biotic Now Available Offering Free Shipping for Certain Purchases

Thursday, September 23, 2021 - 2:24pm

SHERIDAN, Wyo., Sept. 23, 2021 /PRNewswire/ --Boost Biotic, a premium supplement brand, is happy to inform customers that free shipping is now available for certain purchases.

Key Points: 
  • SHERIDAN, Wyo., Sept. 23, 2021 /PRNewswire/ --Boost Biotic, a premium supplement brand, is happy to inform customers that free shipping is now available for certain purchases.
  • The multivitamin vegan supplement with zinc and vitamin B12 for immune support continues to be one of the brand's most popular products.
  • To find more about Boost Biotic multivitamin tablets, visit https://boostbiotic.com/products/advance-defense-immune-support
    "Based on integrative science, the Advance Defense Immune Support is a naturally effective, stimulant-free supplement formulated to boost the body's immune response," said a spokesperson for the brand.
  • Suitable for adults and children 12+, the multivitamin zinc capsules are gluten-free, non-dairy, non-GMO, and keto, paleo, vegan, and vegetarian-friendly.

Next Generation Disinfection Solutions Spread Beyond Healthcare

Thursday, September 23, 2021 - 2:00pm

These grant funds help alleviate product shortages due to supply chain issues that could lead to unfair pricing practices.

Key Points: 
  • These grant funds help alleviate product shortages due to supply chain issues that could lead to unfair pricing practices.
  • Additionally, the demand for personal protective equipment (PPE) over the forecast period is also expected to continue its growth.
  • OPTEC International, Inc.(OTC: OPTI) announced this week breaking news regarding the, "company's subsidiary Z2O territories report Period Ending September 19th, 2021.
  • There is a potential for mask sales to increase again as a result of the recent increased spread of Covid-19, primarily due to the Delta variant.

Next Generation Disinfection Solutions Spread Beyond Healthcare

Thursday, September 23, 2021 - 2:00pm

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Technology has played a major role in helping medical facilities, organizations and governments fight the pandemic. As a result, government funds were used to provide hospital with further necessary technology. Recently, even though the fears from the pandemic have diminished and the economy has largely reopened, the number of new cases due to new variants has increased. As a result, earlier in July, former Governor Andrew M. Cuomo announced that 12 New York companies had received support from the State to produce needed supplies to help combat the pandemic. These grant funds help alleviate product shortages due to supply chain issues that could lead to unfair pricing practices. One of the companies, Shatkin F.I.R.S.T, LLC, has manufactured more than 200,000 N95 respirators, and recently procured a second machine to be able to manufacture millions of N95 respirators. Additionally, the demand for personal protective equipment (PPE) over the forecast period is also expected to continue its growth. According to data provided by Grand View Research, the global personal protective equipment market size was valued at USD 77.36 Billion in 2020 and is expected to grow at a CAGR of 7.3% from 2020 to 2028. OPTEC International, Inc. (OTC: OPTI), Trevena, Inc. (NASDAQ: TRVN), Alpha Pro Tech, Ltd. (NYSE: APT), Allied Healthcare Products, Inc. (NASDAQ: AHPI), Lakeland Industries, Inc. (NASDAQ: LAKE) 

Key Points: 
  • These grant funds help alleviate product shortages due to supply chain issues that could lead to unfair pricing practices.
  • Additionally, the demand for personal protective equipment (PPE) over the forecast period is also expected to continue its growth.
  • OPTEC International, Inc.(OTC: OPTI) announced this week breaking news regarding the, "company's subsidiary Z2O territories report Period Ending September 19th, 2021.
  • There is a potential for mask sales to increase again as a result of the recent increased spread of Covid-19, primarily due to the Delta variant.

A New Neutralizing Antibody Test Shows Your Body's Response to the COVID-19 Vaccine

Thursday, September 23, 2021 - 1:59pm

Our neutralizing antibody test correctly identifies the number of neutralizing antibodies you have with 100% specificity.

Key Points: 
  • Our neutralizing antibody test correctly identifies the number of neutralizing antibodies you have with 100% specificity.
  • Because the neutralizing antibody test is ordered directly by consumers online it is usually not covered by health insurance.
  • Epitome Risk is the only company offering a neutralizing antibody test from the comfort of your own home.
  • Vaccine makers announced that the number of COVID-blocking neutralizing antibodies goes down about six months after you got the vaccine.

Immune System Booster Vitamins Supplements From Esvito Receive Praise for Ease of Use

Thursday, September 23, 2021 - 1:39pm

SHERIDAN, Wyo., Sept. 23, 2021 /PRNewswire/ --Esvito, a health and wellness brand focusing on exceptional quality and services for its customers, has received praise for its immune system booster vitamins supplements from delighted consumers happy with the product's ease of use.

Key Points: 
  • SHERIDAN, Wyo., Sept. 23, 2021 /PRNewswire/ --Esvito, a health and wellness brand focusing on exceptional quality and services for its customers, has received praise for its immune system booster vitamins supplements from delighted consumers happy with the product's ease of use.
  • Impressed Amazon users are happily sharing their positive feedback about the immune supplement.
  • Vitamin D promotes the immune system, focus, bones, muscles and acts as a mood support.
  • Created in the USA, Esvito operates per current Good Manufacturing Practices (GMP), is NSF & UL / NPA-certified and is third-party-inspected.

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

Thursday, September 23, 2021 - 12:00pm

CHATHAM, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it has expanded its research collaboration with Columbia University. The research collaboration is focused on studying immune responses to COVID-19 in healthy volunteers who have recovered from COVID-19 or were asymptomatic, as well as studying in vitro T cell and antibody responses to SARS-CoV-2, the virus that causes COVID-19. The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation for tailoring vaccines and therapeutics to appropriate individuals with precision medicine.

Key Points: 
  • CHATHAM, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it has expanded its research collaboration with Columbia University.
  • The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation for tailoring vaccines and therapeutics to appropriate individuals with precision medicine.
  • This research has the potential to lead to the isolation, characterization and cloning of therapeutically relevant fully human neutralizing monoclonal antibodies to SARS-CoV-2.
  • Such aptamers have the potential to identify biomarkers for protective CoV-2 immunity and accelerate the design of precision medicine-driven vaccines against COVID-19.